Preferred Label : Insulin Glargine;

MeSH definition : A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.;

MeSH synonym : Glargine, Insulin; A21-Gly-B31-Arg-B32-Arg-insulin; A21 Gly B31 Arg B32 Arg insulin; Insulin, Glycyl(A21)-Arginyl(B31,B32); Glargine; Insulin, Gly(A21)-Arg(B31,B32);

DeCS synonym : Basaglar;

MeSH hyponym : lantus; HOE 901; Lantus Solostar; Solostar, Lantus; 901, HOE; HOE-901; HOE901; Glargine-aglr, Insulin; Rezvoglar;

Related MeSH term : Insulin Glargine-yfgn;

MeSH Related Number : 160337-95-1;

Wikipedia link : https://en.wikipedia.org/wiki/Insulin glargine;

Is substance : O;

UNII : 2ZM8CX04RZ;

Details


Main resources

You can consult :

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline

---
https://www.has-sante.fr/jcms/p_3315981/fr/toujeo-solostar-insuline-glargine
2022
false
false
false
France
evaluation of the transparency committee
insulin
Insulin Glargine

---
https://www.has-sante.fr/jcms/p_3194972/fr/toujeo
2020
false
false
false
France
Insulin Glargine
insulin glargine
hypoglycemic agents
adolescent
child
diabetes mellitus, type 1
diabetes mellitus, type 2
evaluation of the transparency committee

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/soliqua-5434.html
2020
false
false
false
Canada
French
insulin glargine and lixisenatide
drug evaluation
Insulin Glargine
drug combinations
diabetes mellitus, type 2
lixisenatide
peptides

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1235
2019
false
false
false
false
France
comparative effectiveness research
hypoglycemic agents
hypoglycemic agents
insulin degludec
Insulin Glargine
cardiovascular diseases
hypoglycemia
diabetes mellitus, type 2
critical appraisal or critical reading
insulin degludec
diabetes mellitus, type 2
Insulin Glargine
insulin, long-acting
insulin, long-acting

---
https://www.has-sante.fr/jcms/p_3098014/fr/toujeo-doublestar
2019
false
false
false
France
evaluation of the transparency committee
Insulin Glargine

---
https://www.ema.europa.eu/medicines/human/EPAR/Semglee
2018
false
United Kingdom
French
English
syndication feed
Insulin Glargine
Insulin Glargine
biosimilar pharmaceuticals
drug approval
europe
Insulin glargine 100units/mL injection solution 3mL cartridge (product)
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device (product)
child, preschool
diabetes mellitus
adult
child
adolescent
hypoglycemic agents
hypoglycemic agents
treatment outcome
drug evaluation
injections, subcutaneous
insulin glargine
drug evaluation
summary of product characteristics
package leaflet

---
https://www.has-sante.fr/portail/jcms/c_2848651/fr/lantus-toujeo
2018
false
false
false
false
France
French
evaluation of the transparency committee
lantus
Insulin Glargine

---
https://www.ema.europa.eu/medicines/human/EPAR/Suliqua
2017
false
United Kingdom
English
French
Glucagon-Like Peptide-1 Receptor
drug combinations
metformin
Insulin Glargine
Insulin Glargine
Pre-filled Pen Syringe
insulin glargine and lixisenatide
europe
drug approval
treatment outcome
adult
diabetes mellitus, type 2
drug therapy, combination
hypoglycemic agents
hypoglycemic agents
injections, subcutaneous
drug interactions
pregnancy
breast feeding
randomized controlled trials as topic
Glycated Hemoglobin
blood glucose
body weight
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
lixisenatide
lixisenatide
peptides
peptides

---
Lusduna - insulin glargine
https://www.ema.europa.eu/medicines/human/EPAR/Lusduna
2017
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
insulin glargine
adult
child
diabetes mellitus
hypoglycemic agents
hypoglycemic agents
Pre-filled Pen Syringe
injections, subcutaneous
product surveillance, postmarketing
adolescent
aged
drug interactions
pregnancy
breast feeding
biosimilar pharmaceuticals
Insulin Glargine
Insulin Glargine
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device (product)

---
https://www.minerva-ebp.be/FR/Analysis/455
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
patient care management
treatment outcome
Insulin Glargine
pharmacists

---
https://www.ema.europa.eu/medicines/human/EPAR/abasaglar-previously-abasria
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
insulin glargine
adult
child
diabetes mellitus
hypoglycemic agents
hypoglycemic agents
Cartridge
Pre-filled Pen Syringe
injections, subcutaneous
product surveillance, postmarketing
adolescent
aged
drug interactions
pregnancy
breast feeding
biosimilar pharmaceuticals
Insulin Glargine
Insulin Glargine

---
http://www.has-sante.fr/portail/jcms/c_2569216/fr/abasaglar
2015
false
false
false
false
France
French
evaluation of the transparency committee
diabetes mellitus
adult
adolescent
child
hypoglycemic agents
hypoglycemic agents
insulin glargine
biosimilar pharmaceuticals
insurance, health, reimbursement
treatment outcome
injections, subcutaneous
Insulin glargine 100units/mL injection solution 3mL cartridge (product)
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device (product)
Insulin Glargine
Insulin Glargine

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00281
2015
false
false
false
false
Canada
French
drug information
Insulin Glargine
insulin glargine
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device (product)
Insulin glargine 100units/mL injection solution 3mL cartridge (product)

---
http://www.has-sante.fr/portail/jcms/c_2569089/fr/toujeo
2015
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
injections, subcutaneous
hypoglycemic agents
hypoglycemic agents
insulin glargine
diabetes mellitus
adult
Insulin Glargine
Insulin Glargine

---
http://www.has-sante.fr/portail/jcms/c_1749754/fr/lantus-insuline-glargine-antidiabetique-injectable
2014
false
France
French
diabetes mellitus, type 2
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
guidelines for drug use
Insulin Glargine
Insulin Glargine
insulin
hypoglycemic agents
hypoglycemic agents
insulin glargine
diabetes mellitus, type 1
adolescent
adult
child
injections, subcutaneous

---
http://www.has-sante.fr/portail/jcms/c_1749754/fr/lantus
http://www.has-sante.fr/portail/jcms/c_1722903/fr/lantus
2014
false
France
French
evaluation of the transparency committee
injections, subcutaneous
insurance, health, reimbursement
child
diabetes mellitus, type 1
insulin glargine
treatment outcome
hypoglycemic agents
hypoglycemic agents
diabetes mellitus, type 2
adult
adolescent
guidelines for drug use
Insulin Glargine
Insulin Glargine

---
https://www.minerva-ebp.be/fr/article/1046
2014
false
false
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
diabetes mellitus, type 2
hypoglycemic agents
insulins
insulins
biphasic insulins
insulin, long-acting
drug administration schedule
Insulin Glargine
comparative study

---
https://www.ema.europa.eu/medicines/human/EPAR/toujeo-previously-optisulin
2012
false
United Kingdom
English
French
syndication feed
Insulin Glargine
Insulin Glargine
hypoglycemic agents
diabetes mellitus
hypoglycemic agents
treatment outcome
drug evaluation
adult
injections, subcutaneous
insulin glargine
package leaflet
drug evaluation
summary of product characteristics

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2012-insuline-glargine-cancers
2012
France
technical report
patients
Diabetes mellitus type 2
Insulin Glargine
risk
has patient
diabetes mellitus, type 2
insulin
diabetes non-insulin dependent

---
http://www.cochrane.org/fr/CD006383
2011
false
United Kingdom
France
French
Insulin Glargine
Insulin Detemir
meta-analysis
diabetes mellitus, type 2
insulin detemir
insulin glargine
injections, subcutaneous
hypoglycemic agents
randomized controlled trials as topic
french abstract

---
http://www.has-sante.fr/portail/jcms/c_1097691/lantus-insuline-glargine-synthese-d-avis
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/lantus_-_ct-_9433.pdf
2011
false
France
French
evaluation of the transparency committee
guidelines for drug use
Insulin Glargine
Insulin Glargine
hypoglycemic agents
hypoglycemic agents
insulin glargine
diabetes mellitus
adolescent
adult
child
injections, subcutaneous
neoplasms

---
http://www.has-sante.fr/portail/jcms/c_1062696/lantus
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/lantus_-_ct-_9433.pdf
2011
false
France
French
evaluation of the transparency committee
Insulin Glargine
Insulin Glargine
hypoglycemic agents
insulin
hypoglycemic agents
injections, subcutaneous
insulin glargine
diabetes mellitus
adult
adolescent
child
risk assessment
neoplasms
insulin

---
https://www.ema.europa.eu/medicines/human/EPAR/Lantus
2010
false
United Kingdom
French
English
syndication feed
Insulin Glargine
Insulin Glargine
diabetes mellitus
adult
child
adolescent
hypoglycemic agents
hypoglycemic agents
treatment outcome
drug evaluation
injections, subcutaneous
insulin glargine
drug evaluation
summary of product characteristics
package leaflet

---
https://rmlg.uliege.be/article/1926
2009
false
Belgium
French
Insulin Glargine
Insulin Glargine
diabetes mellitus
risk
hypoglycemic agents
hypoglycemic agents
insulin glargine
breast neoplasms
journal article

---
https://www.minerva-ebp.be/fr/article/660
2007
false
false
minerva-ebm.be
Belgium
French
Insulin Glargine
hypoglycemic agents
diabetes mellitus, type 2
drug therapy, combination
thiazolidinediones
metformin
treatment outcome
Glycated Hemoglobin
blood glucose
administration, oral
injections
critical appraisal or critical reading
comparative study
Rosiglitazone

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Lantus_Resubmission-Fr.pdf
2006
false
Canada
French
Insulin Glargine
injections, subcutaneous
hypoglycemic agents
diabetes mellitus
insulin glargine
drug evaluation

---
https://www.jle.com/fr/revues/medecine/med/e-docs/00/04/13/8D/article.md?type=text.html
2005
false
France
French
Insulin Glargine
Insulin Detemir
insulin
diabetes mellitus, type 1
hypoglycemic agents
treatment outcome
hypoglycemia
weight gain
diabetes mellitus, type 2
insulin detemir
insulin glargine
journal article

---
https://pgtmsite.files.wordpress.com/2024/01/insulineglargine_pgtm_20050922.pdf
2005
Canada
drug information
insulin
Insulin Glargine
Insulin Glargine

---
https://www.cadth.ca/sites/default/files/pdf/284_insulinglargine_cetap_f.pdf
2004
false
Canada
French
Insulin Glargine
treatment outcome
diabetes mellitus, type 2
clinical trials as topic
hypoglycemic agents
Evidence-Based medicine
insulin glargine
injections, subcutaneous
Glycated Hemoglobin
hypoglycemia
comparative study
evaluation studies
journal article

---
https://rmlg.uliege.be/article/1019
2004
false
Belgium
French
Insulin Glargine
Insulin Glargine
hypoglycemic agents
injections, subcutaneous
insulin
hypoglycemic agents
drug therapy, combination
diabetes mellitus
insulin glargine
drug information
journal article

---
https://www.cadth.ca/sites/default/files/pdf/259_insulin_glargine_cetap_f.pdf
2003
false
Canada
French
Insulin Glargine
journal article
table
diabetes mellitus, type 1
hypoglycemic agents
treatment outcome
Evidence-Based medicine
costs and cost analysis
insulin, isophane
insulin glargine
injections, subcutaneous
drug evaluation
comparative study

---
https://www.cadth.ca/sites/default/files/pdf/108_No8_glargine_edrug_f.pdf
https://www.cadth.ca/sites/default/files/pdf/108_No8_glargine_edrug_e.pdf
2001
false
Canada
French
English
Insulin Glargine
hypoglycemic agents
canada
treatment outcome
Evidence-Based medicine
injections, subcutaneous
diabetes mellitus
insulin glargine
recombinant proteins
drug evaluation

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.